AV Therapeutics, Inc.
AV Therapeutics, Inc. (AVTH) is a publicly traded company in the Unknown sector. Across all available filings, 1 corporate insiders have executed 2 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Jan 20, 2015 involved a transaction of 1,200,000 shares valued at $0.
AVTH Recent Transactions
2 transactionsDate | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 20, 2015 | Mittelman Abraham | Executive | Other | 1,200,000 | $N/A | $0 | |
| Jul 14, 2014 | Mittelman Abraham | Executive | Other | 650,000 | $N/A | $0 |
AVTH Insider Activity Summary
Who Is Buying AVTH Stock?
No significant insider buying has been recorded for AVTH in the recent period.
Who Is Selling AVTH Stock?
No significant insider selling has been recorded for AVTH in the recent period.
Is AV Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AVTH is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
AVTH Frequently Asked Questions
Understanding AVTH Insider Activity
Insider trading at AV Therapeutics, Inc. (AVTH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 1 insiders are actively trading AVTH stock, having executed 2 transactions in the past 90 days. The most active insider is Abraham Mittelman (Executive), who has made 2 transactions totaling $0.
Related Tools
Track AV Therapeutics, Inc. Insider Activity
Get notified when executives and directors at AVTH file new Form 4 transactions